Medical Care

Global CRISPR Gene Testing and Diagnostics Market Research Report 2025

The global market for CRISPR Gene Testing and Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CRISPR Gene Testing and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Gene Testing and Diagnostics.
The CRISPR Gene Testing and Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR Gene Testing and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Gene Testing and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
Aelian Biotechnology
Agilent Technologies
Axxam
Beckman Coulter
Becton, Dickinson and Company
Binx Health
bioMérieux
Bio-Rad Laboratories
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
Segment by Type
Animals
Plants
Pathogens
Others
Segment by Application
Medical Industry
Agriculture
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Gene Testing and Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Animals
1.2.3 Plants
1.2.4 Pathogens
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Gene Testing and Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Industry
1.3.3 Agriculture
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Gene Testing and Diagnostics Market Perspective (2020-2031)
2.2 Global CRISPR Gene Testing and Diagnostics Growth Trends by Region
2.2.1 Global CRISPR Gene Testing and Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRISPR Gene Testing and Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 CRISPR Gene Testing and Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 CRISPR Gene Testing and Diagnostics Market Dynamics
2.3.1 CRISPR Gene Testing and Diagnostics Industry Trends
2.3.2 CRISPR Gene Testing and Diagnostics Market Drivers
2.3.3 CRISPR Gene Testing and Diagnostics Market Challenges
2.3.4 CRISPR Gene Testing and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Gene Testing and Diagnostics Players by Revenue
3.1.1 Global Top CRISPR Gene Testing and Diagnostics Players by Revenue (2020-2025)
3.1.2 Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global CRISPR Gene Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRISPR Gene Testing and Diagnostics Revenue
3.4 Global CRISPR Gene Testing and Diagnostics Market Concentration Ratio
3.4.1 Global CRISPR Gene Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Gene Testing and Diagnostics Revenue in 2024
3.5 Global Key Players of CRISPR Gene Testing and Diagnostics Head office and Area Served
3.6 Global Key Players of CRISPR Gene Testing and Diagnostics, Product and Application
3.7 Global Key Players of CRISPR Gene Testing and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Gene Testing and Diagnostics Breakdown Data by Type
4.1 Global CRISPR Gene Testing and Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Type (2026-2031)
5 CRISPR Gene Testing and Diagnostics Breakdown Data by Application
5.1 Global CRISPR Gene Testing and Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRISPR Gene Testing and Diagnostics Market Size (2020-2031)
6.2 North America CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025)
6.4 North America CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Gene Testing and Diagnostics Market Size (2020-2031)
7.2 Europe CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025)
7.4 Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Gene Testing and Diagnostics Market Size (2020-2031)
9.2 Latin America CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025)
9.4 Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Details
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Introduction
11.1.4 10x Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.1.5 10x Genomics Recent Development
11.2 Aelian Biotechnology
11.2.1 Aelian Biotechnology Company Details
11.2.2 Aelian Biotechnology Business Overview
11.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Introduction
11.2.4 Aelian Biotechnology Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.2.5 Aelian Biotechnology Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Introduction
11.3.4 Agilent Technologies Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.3.5 Agilent Technologies Recent Development
11.4 Axxam
11.4.1 Axxam Company Details
11.4.2 Axxam Business Overview
11.4.3 Axxam CRISPR Gene Testing and Diagnostics Introduction
11.4.4 Axxam Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.4.5 Axxam Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Introduction
11.5.4 Beckman Coulter Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.5.5 Beckman Coulter Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Introduction
11.6.4 Becton, Dickinson and Company Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Binx Health
11.7.1 Binx Health Company Details
11.7.2 Binx Health Business Overview
11.7.3 Binx Health CRISPR Gene Testing and Diagnostics Introduction
11.7.4 Binx Health Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.7.5 Binx Health Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Details
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux CRISPR Gene Testing and Diagnostics Introduction
11.8.4 bioMérieux Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Introduction
11.9.4 Bio-Rad Laboratories Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Caspr Biotech
11.10.1 Caspr Biotech Company Details
11.10.2 Caspr Biotech Business Overview
11.10.3 Caspr Biotech CRISPR Gene Testing and Diagnostics Introduction
11.10.4 Caspr Biotech Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.10.5 Caspr Biotech Recent Development
11.11 ERS Genomics
11.11.1 ERS Genomics Company Details
11.11.2 ERS Genomics Business Overview
11.11.3 ERS Genomics CRISPR Gene Testing and Diagnostics Introduction
11.11.4 ERS Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.11.5 ERS Genomics Recent Development
11.12 FASMAC
11.12.1 FASMAC Company Details
11.12.2 FASMAC Business Overview
11.12.3 FASMAC CRISPR Gene Testing and Diagnostics Introduction
11.12.4 FASMAC Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.12.5 FASMAC Recent Development
11.13 Illumina
11.13.1 Illumina Company Details
11.13.2 Illumina Business Overview
11.13.3 Illumina CRISPR Gene Testing and Diagnostics Introduction
11.13.4 Illumina Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.13.5 Illumina Recent Development
11.14 Janssen Diagnostics
11.14.1 Janssen Diagnostics Company Details
11.14.2 Janssen Diagnostics Business Overview
11.14.3 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Introduction
11.14.4 Janssen Diagnostics Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.14.5 Janssen Diagnostics Recent Development
11.15 Locus Biosciences
11.15.1 Locus Biosciences Company Details
11.15.2 Locus Biosciences Business Overview
11.15.3 Locus Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.15.4 Locus Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.15.5 Locus Biosciences Recent Development
11.16 Mammoth Biosciences
11.16.1 Mammoth Biosciences Company Details
11.16.2 Mammoth Biosciences Business Overview
11.16.3 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.16.4 Mammoth Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.16.5 Mammoth Biosciences Recent Development
11.17 NRGene
11.17.1 NRGene Company Details
11.17.2 NRGene Business Overview
11.17.3 NRGene CRISPR Gene Testing and Diagnostics Introduction
11.17.4 NRGene Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.17.5 NRGene Recent Development
11.18 Roche
11.18.1 Roche Company Details
11.18.2 Roche Business Overview
11.18.3 Roche CRISPR Gene Testing and Diagnostics Introduction
11.18.4 Roche Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.18.5 Roche Recent Development
11.19 Sherlock Biosciences
11.19.1 Sherlock Biosciences Company Details
11.19.2 Sherlock Biosciences Business Overview
11.19.3 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.19.4 Sherlock Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.19.5 Sherlock Biosciences Recent Development
11.20 Thermo Fisher Scientific
11.20.1 Thermo Fisher Scientific Company Details
11.20.2 Thermo Fisher Scientific Business Overview
11.20.3 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Introduction
11.20.4 Thermo Fisher Scientific Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.20.5 Thermo Fisher Scientific Recent Development
11.21 Vivlion
11.21.1 Vivlion Company Details
11.21.2 Vivlion Business Overview
11.21.3 Vivlion CRISPR Gene Testing and Diagnostics Introduction
11.21.4 Vivlion Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025)
11.21.5 Vivlion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Animals
Table 3. Key Players of Plants
Table 4. Key Players of Pathogens
Table 5. Key Players of Others
Table 6. Global CRISPR Gene Testing and Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CRISPR Gene Testing and Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global CRISPR Gene Testing and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global CRISPR Gene Testing and Diagnostics Market Share by Region (2020-2025)
Table 10. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global CRISPR Gene Testing and Diagnostics Market Share by Region (2026-2031)
Table 12. CRISPR Gene Testing and Diagnostics Market Trends
Table 13. CRISPR Gene Testing and Diagnostics Market Drivers
Table 14. CRISPR Gene Testing and Diagnostics Market Challenges
Table 15. CRISPR Gene Testing and Diagnostics Market Restraints
Table 16. Global CRISPR Gene Testing and Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global CRISPR Gene Testing and Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top CRISPR Gene Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Testing and Diagnostics as of 2024)
Table 19. Ranking of Global Top CRISPR Gene Testing and Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by CRISPR Gene Testing and Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of CRISPR Gene Testing and Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of CRISPR Gene Testing and Diagnostics, Product and Application
Table 23. Global Key Players of CRISPR Gene Testing and Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRISPR Gene Testing and Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global CRISPR Gene Testing and Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. 10x Genomics Company Details
Table 49. 10x Genomics Business Overview
Table 50. 10x Genomics CRISPR Gene Testing and Diagnostics Product
Table 51. 10x Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 52. 10x Genomics Recent Development
Table 53. Aelian Biotechnology Company Details
Table 54. Aelian Biotechnology Business Overview
Table 55. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product
Table 56. Aelian Biotechnology Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Aelian Biotechnology Recent Development
Table 58. Agilent Technologies Company Details
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies CRISPR Gene Testing and Diagnostics Product
Table 61. Agilent Technologies Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Agilent Technologies Recent Development
Table 63. Axxam Company Details
Table 64. Axxam Business Overview
Table 65. Axxam CRISPR Gene Testing and Diagnostics Product
Table 66. Axxam Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Axxam Recent Development
Table 68. Beckman Coulter Company Details
Table 69. Beckman Coulter Business Overview
Table 70. Beckman Coulter CRISPR Gene Testing and Diagnostics Product
Table 71. Beckman Coulter Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Beckman Coulter Recent Development
Table 73. Becton, Dickinson and Company Company Details
Table 74. Becton, Dickinson and Company Business Overview
Table 75. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Product
Table 76. Becton, Dickinson and Company Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Becton, Dickinson and Company Recent Development
Table 78. Binx Health Company Details
Table 79. Binx Health Business Overview
Table 80. Binx Health CRISPR Gene Testing and Diagnostics Product
Table 81. Binx Health Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Binx Health Recent Development
Table 83. bioMérieux Company Details
Table 84. bioMérieux Business Overview
Table 85. bioMérieux CRISPR Gene Testing and Diagnostics Product
Table 86. bioMérieux Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 87. bioMérieux Recent Development
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product
Table 91. Bio-Rad Laboratories Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. Caspr Biotech Company Details
Table 94. Caspr Biotech Business Overview
Table 95. Caspr Biotech CRISPR Gene Testing and Diagnostics Product
Table 96. Caspr Biotech Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Caspr Biotech Recent Development
Table 98. ERS Genomics Company Details
Table 99. ERS Genomics Business Overview
Table 100. ERS Genomics CRISPR Gene Testing and Diagnostics Product
Table 101. ERS Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 102. ERS Genomics Recent Development
Table 103. FASMAC Company Details
Table 104. FASMAC Business Overview
Table 105. FASMAC CRISPR Gene Testing and Diagnostics Product
Table 106. FASMAC Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 107. FASMAC Recent Development
Table 108. Illumina Company Details
Table 109. Illumina Business Overview
Table 110. Illumina CRISPR Gene Testing and Diagnostics Product
Table 111. Illumina Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 112. Illumina Recent Development
Table 113. Janssen Diagnostics Company Details
Table 114. Janssen Diagnostics Business Overview
Table 115. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product
Table 116. Janssen Diagnostics Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 117. Janssen Diagnostics Recent Development
Table 118. Locus Biosciences Company Details
Table 119. Locus Biosciences Business Overview
Table 120. Locus Biosciences CRISPR Gene Testing and Diagnostics Product
Table 121. Locus Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 122. Locus Biosciences Recent Development
Table 123. Mammoth Biosciences Company Details
Table 124. Mammoth Biosciences Business Overview
Table 125. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product
Table 126. Mammoth Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 127. Mammoth Biosciences Recent Development
Table 128. NRGene Company Details
Table 129. NRGene Business Overview
Table 130. NRGene CRISPR Gene Testing and Diagnostics Product
Table 131. NRGene Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 132. NRGene Recent Development
Table 133. Roche Company Details
Table 134. Roche Business Overview
Table 135. Roche CRISPR Gene Testing and Diagnostics Product
Table 136. Roche Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 137. Roche Recent Development
Table 138. Sherlock Biosciences Company Details
Table 139. Sherlock Biosciences Business Overview
Table 140. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product
Table 141. Sherlock Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 142. Sherlock Biosciences Recent Development
Table 143. Thermo Fisher Scientific Company Details
Table 144. Thermo Fisher Scientific Business Overview
Table 145. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product
Table 146. Thermo Fisher Scientific Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 147. Thermo Fisher Scientific Recent Development
Table 148. Vivlion Company Details
Table 149. Vivlion Business Overview
Table 150. Vivlion CRISPR Gene Testing and Diagnostics Product
Table 151. Vivlion Revenue in CRISPR Gene Testing and Diagnostics Business (2020-2025) & (US$ Million)
Table 152. Vivlion Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report


List of Figures
Figure 1. CRISPR Gene Testing and Diagnostics Picture
Figure 2. Global CRISPR Gene Testing and Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CRISPR Gene Testing and Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Animals Features
Figure 5. Plants Features
Figure 6. Pathogens Features
Figure 7. Others Features
Figure 8. Global CRISPR Gene Testing and Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global CRISPR Gene Testing and Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Medical Industry Case Studies
Figure 11. Agriculture Case Studies
Figure 12. Others Case Studies
Figure 13. CRISPR Gene Testing and Diagnostics Report Years Considered
Figure 14. Global CRISPR Gene Testing and Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global CRISPR Gene Testing and Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global CRISPR Gene Testing and Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global CRISPR Gene Testing and Diagnostics Market Share by Players in 2024
Figure 18. Global Top CRISPR Gene Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Testing and Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by CRISPR Gene Testing and Diagnostics Revenue in 2024
Figure 20. North America CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America CRISPR Gene Testing and Diagnostics Market Share by Country (2020-2031)
Figure 22. United States CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CRISPR Gene Testing and Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Share by Region (2020-2031)
Figure 34. China CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CRISPR Gene Testing and Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. 10x Genomics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 50. Aelian Biotechnology Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 51. Agilent Technologies Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 52. Axxam Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 53. Beckman Coulter Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 54. Becton, Dickinson and Company Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 55. Binx Health Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 56. bioMérieux Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 58. Caspr Biotech Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 59. ERS Genomics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 60. FASMAC Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 61. Illumina Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 62. Janssen Diagnostics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 63. Locus Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 64. Mammoth Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 65. NRGene Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 66. Roche Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 67. Sherlock Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 68. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 69. Vivlion Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies